Barbara Ruskin

Barbara Ruskin, Ph.D., J.D. brings over 25 years of experience in life science IP and corporate law, having served as outside counsel for pharmaceutical and biotechnology companies and their investors, including as a Partner at Ropes& Gray LLP and an associate at Fish & Neave LLP, both in New York City. From September 2017 to February 2019, Dr. Ruskin served as SVP General Counsel/Chief Patent Officer of Molecular Templates, Inc. (Nasdaq: MTEM) and from April 2015 to August 2016, as SVP, General Counsel/Chief Patent Officer of Bionor Pharma ASA, a public company in Oslo, Norway. At each company, she managed general legal and intellectual property matters, including corporate financing and regulatory matters, business development, licensing, and patent portfolio management.

Dr. Ruskin earned a B.A. in Biochemistry from the University of California, Berkeley, a Ph.D. in Biochemistry and Molecular Biology from Harvard University, and a J.D. from Fordham University School of Law. She is admitted to practice law in New York State and is a registered United States Patent Attorney. She currently serves as Chairman of the Board of St. Jude Children's Hospital GMP, LLC and has previously served as a director on the Board of the Burke Neurological Institute.